PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cmrPermissionsJournals.ASM.orgJournalCMR ArticleJournal InfoAuthorsReviewers
 
Clin Microbiol Rev. 1988 January; 1(1): 1–18.
PMCID: PMC358025

Clostridium difficile: its disease and toxins.

Abstract

Clostridium difficile is the etiologic agent of pseudomembranous colitis, a severe, sometimes fatal disease that occurs in adults undergoing antimicrobial therapy. The disease, ironically, has been most effectively treated with antibiotics, although some of the newer methods of treatment such as the replacement of the bowel flora may prove more beneficial for patients who continue to relapse with pseudomembranous colitis. The organism produces two potent exotoxins designated toxin A and toxin B. Toxin A is an enterotoxin believed to be responsible for the diarrhea and mucosal tissue damage which occur during the disease. Toxin B is an extremely potent cytotoxin, but its role in the disease has not been as well studied. There appears to be a cascade of events which result in the expression of the activity of these toxins, and these events, ranging from the recognition of a trisaccharide receptor by toxin A to the synergistic action of the toxins and their possible dissemination in the body, are discussed in this review. The advantages and disadvantages of the various assays, including tissue culture assay, enzyme immunoassay, and latex agglutination, currently used in the clinical diagnosis of the disease also are discussed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (3.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abrams GD, Allo M, Rifkin GD, Fekety R, Silva J., Jr Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. Gut. 1980 Jun;21(6):493–499. [PMC free article] [PubMed]
  • Adler SP, Chandrika T, Berman WF. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Am J Dis Child. 1981 Sep;135(9):820–822. [PubMed]
  • Ahlgren T, Florin I, Jarstrand C, Thelestam M. Loss of surface fibronectin from human lung fibroblasts exposed to cytotoxin from Clostridium difficile. Infect Immun. 1983 Mar;39(3):1470–1472. [PMC free article] [PubMed]
  • Al-Jumaili IJ, Bint AJ. Simple method for isolation and presumptive identification of Clostridium difficile. Zentralbl Bakteriol Mikrobiol Hyg A. 1981;250(1-2):142–146. [PubMed]
  • Al-Jumaili IJ, Shibley M, Lishman AH, Record CO. Incidence and origin of Clostridium difficile in neonates. J Clin Microbiol. 1984 Jan;19(1):77–78. [PMC free article] [PubMed]
  • Allo M, Silva J, Jr, Fekety R, Rifkin GD, Waskin H. Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology. 1979 Feb;76(2):351–355. [PubMed]
  • Al-Mashat RR, Taylor DJ. Bacteria in enteric lesions of cattle. Vet Rec. 1983 Jan 1;112(1):5–10. [PubMed]
  • Aronsson B, Granström M, Möllby R, Nord CE. Enzyme immunoassay for detection of Clostridium difficile toxins A and B in patients with antibiotic-associated diarrhoea and colitis. Eur J Clin Microbiol. 1985 Apr;4(2):102–107. [PubMed]
  • Nachamkin I, Lotz-Nolan L, Skalina D. Evaluation of a commercial cytotoxicity assay for detection of Clostridium difficile toxin. J Clin Microbiol. 1986 May;23(5):954–955. [PMC free article] [PubMed]
  • Banno Y, Kobayashi T, Kono H, Watanabe K, Ueno K, Nozawa Y. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. Rev Infect Dis. 1984 Mar-Apr;6 (Suppl 1):S11–S20. [PubMed]
  • Bartlett JG. Antibiotic-associated pseudomembranous colitis. Rev Infect Dis. 1979 May-Jun;1(3):530–539. [PubMed]
  • Bartlett JG. Treatment of antibiotic-associated pseudomembranous colitis. Rev Infect Dis. 1984 Mar-Apr;6 (Suppl 1):S235–S241. [PubMed]
  • Bartlett JG. Treatment of Clostridium difficile colitis. Gastroenterology. 1985 Nov;89(5):1192–1195. [PubMed]
  • Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531–534. [PubMed]
  • Bartlett JG, Chang TW, Moon N, Onderdonk AB. Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am J Vet Res. 1978 Sep;39(9):1525–1530. [PubMed]
  • Bartlett JG, Chang T, Taylor NS, Onderdonk AB. Colitis induced by Clostridium difficile. Rev Infect Dis. 1979 Mar-Apr;1(2):370–378. [PubMed]
  • Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978 Nov;75(5):778–782. [PubMed]
  • Bartlett JG, Onderdonk AB, Cisneros RL. Clindamycin-associated colitis in hamsters: protection with vancomycin. Gastroenterology. 1977 Oct;73(4 Pt 1):772–776. [PubMed]
  • Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis. 1977 Nov;136(5):701–705. [PubMed]
  • Bartlett JG, Taylor NS, Chang T, Dzink J. Clinical and laboratory observations in Clostridium difficile colitis. Am J Clin Nutr. 1980 Nov;33(11 Suppl):2521–2526. [PubMed]
  • Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang T. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology. 1980 Mar;78(3):431–434. [PubMed]
  • Bartlett JG, Willey SH, Chang TW, Lowe B. Cephalosporin-associated pseudomembranous colitis due to Clostridium difficile. JAMA. 1979 Dec 14;242(24):2683–2685. [PubMed]
  • Bate G. Comparison of Minitek Anaerobe II, API An-Ident, and RapID ANA systems for identification of Clostridium difficile. Am J Clin Pathol. 1986 Jun;85(6):716–718. [PubMed]
  • Boenning DA, Fleisher GR, Campos JM, Hulkower CW, Quinlan RW. Clostridium difficile in a pediatric outpatient population. Pediatr Infect Dis. 1982 Sep-Oct;1(5):336–338. [PubMed]
  • Bolton RP, Culshaw MA. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut. 1986 Oct;27(10):1169–1172. [PMC free article] [PubMed]
  • Bolton RP, Sherriff RJ, Read AE. Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease? Lancet. 1980 Feb 23;1(8165):383–384. [PubMed]
  • Bolton RP, Tait SK, Dear PR, Losowsky MS. Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child. 1984 May;59(5):466–472. [PMC free article] [PubMed]
  • Borriello SP, Barclay FE. An in-vitro model of colonisation resistance to Clostridium difficile infection. J Med Microbiol. 1986 Jun;21(4):299–309. [PubMed]
  • Borriello SP, Barclay FE, Reed PJ, Welch AR, Brown JD, Burdon DW. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein. J Clin Pathol. 1987 May;40(5):573–580. [PMC free article] [PubMed]
  • Bowden TA, Jr, Mansberger AR, Jr, Lykins LE. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg. 1981 Apr;47(4):178–183. [PubMed]
  • Brettle RP, Wallace E. Clostridium difficile-associated diarrhoea. J Infect. 1984 Mar;8(2):123–128. [PubMed]
  • Brook I. Isolation of toxin producing Clostridium difficile from two children with oxacillin- and dicloxacillin-associated diarrhea. Pediatrics. 1980 Jun;65(6):1154–1156. [PubMed]
  • Browne RA, Fekety R, Jr, Silva J, Jr, Boyd DI, Work CO, Abrams GD. The protective effect of vancomycin on clindamycin-induced colitis in hamsters. Johns Hopkins Med J. 1977 Oct;141(4):183–192. [PubMed]
  • Buggy BP, Wilson KH, Fekety R. Comparison of methods for recovery of Clostridium difficile from an environmental surface. J Clin Microbiol. 1983 Aug;18(2):348–352. [PMC free article] [PubMed]
  • Burdon DW, Brown JD, Youngs DJ, Arabi Y, Shinagawa N, Alexander-Williams J, Keighley MR, George RH. Antibiotic susceptibility of Clostridium difficile. J Antimicrob Chemother. 1979 May;5(3):307–310. [PubMed]
  • Cashore WJ, Peter G, Lauermann M, Stonestreet BS, Oh W. Clostridia colonization and clostridial toxin in neonatal necrotizing enterocolitis. J Pediatr. 1981 Feb;98(2):308–311. [PubMed]
  • Chang TW, Bartlett JG, Gorbach SL, Onderdonk AB. Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun. 1978 May;20(2):526–529. [PMC free article] [PubMed]
  • Chang TW, Gorbach SL, Bartlett JG. Inhibition of binding of Clostridium difficile toxin by steroids. J Infect Dis. 1980 Jul;142(1):113–113. [PubMed]
  • Chang TW, Sullivan NM, Wilkins TD. Insusceptibility of fetal intestinal mucosa and fetal cells to Clostridium difficile toxins. Zhongguo Yao Li Xue Bao. 1986 Sep;7(5):448–453. [PubMed]
  • Colardyn F, Verschraegen G, Claeys G, Vogelaers D. Clostridium difficile-associated diarrhoea during treatment with imipenem. Eur J Clin Microbiol. 1984 Dec;3(6):565–566. [PubMed]
  • Collignon A, Cotte-Laffitte J, Quero AM, Torlotin JC. Clostridium difficile et sa cytotoxine dans les selles de jeunes enfants hospitalisés. Influence du traitement antibiotique. Pathol Biol (Paris) 1986 Nov;34(9):977–982. [PubMed]
  • Corthier G, Dubos F, Raibaud P. Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Appl Environ Microbiol. 1985 Jan;49(1):250–252. [PMC free article] [PubMed]
  • Cudmore MA, Silva J, Jr, Fekety R, Liepman MK, Kim KH. Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med. 1982 Feb;142(2):333–335. [PubMed]
  • Czuprynski CJ, Johnson WJ, Balish E, Wilkins T. Pseudomembranous colitis in Clostridium difficile-monoassociated rats. Infect Immun. 1983 Mar;39(3):1368–1376. [PMC free article] [PubMed]
  • D'Ari L, Barker HA. p-Cresol formation by cell-free extracts of Clostridium difficile. Arch Microbiol. 1985 Dec;143(3):311–312. [PubMed]
  • Decaux GM, Devroede C. Acute colitis related to spiramycin. Lancet. 1978 Nov 4;2(8097):993–993. [PubMed]
  • Deery HG, Jones PG, Kauffman CA, Fekety R, Silva J, Sell TL, Supena RB. Effect of therapy with latamoxef (moxalactam) on carriage of Clostridium difficile. J Antimicrob Chemother. 1984 May;13(5):521–524. [PubMed]
  • Delmee M, Bulliard G, Simon G. Application of a technique for serogrouping Clostridium difficile in an outbreak of antibiotic-associated diarrhoea. J Infect. 1986 Jul;13(1):5–9. [PubMed]
  • Donta ST, Myers MG. Clostridium difficile toxin in asymptomatic neonates. J Pediatr. 1982 Mar;100(3):431–434. [PubMed]
  • Dorman SA, Liggoria E, Winn WC, Jr, Beeken WL. Isolation of Clostridium difficile from patients with inactive Crohn's disease. Gastroenterology. 1982 Jun;82(6):1348–1351. [PubMed]
  • Dudley MN, McLaughlin JC, Carrington G, Frick J, Nightingale CH, Quintiliani R. Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. Arch Intern Med. 1986 Jun;146(6):1101–1104. [PubMed]
  • Dzink J, Bartlett JG. In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrob Agents Chemother. 1980 Apr;17(4):695–698. [PMC free article] [PubMed]
  • Ehrich M, Van Tassell RL, Libby JM, Wilkins TD. Production of Clostridium difficile antitoxin. Infect Immun. 1980 Jun;28(3):1041–1043. [PMC free article] [PubMed]
  • Ellis ME, Watson BM, Milewski PJ, Jones G. Clostridium difficile colitis unassociated with antibiotic therapy. Br J Surg. 1983 Apr;70(4):242–243. [PubMed]
  • Elmer GW, McFarland LV. Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters. Antimicrob Agents Chemother. 1987 Jan;31(1):129–131. [PMC free article] [PubMed]
  • Eto T, Ichikawa Y, Nishimura K, Ando S, Yamakawa T. Chemistry of lipid of the posthemyolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes of rabbit. J Biochem. 1968 Aug;64(2):205–213. [PubMed]
  • Fekety R, Silva J, Armstrong J, Allo M, Browne R, Ebright J, Lusk R, Rifkin G, Toshniwal R. Treatment of antibiotic-associated enterocolitis with vancomycin. Rev Infect Dis. 1981 Nov-Dec;3 Suppl:S273–S281. [PubMed]
  • Fekety R, Silva J, Toshniwal R, Allo M, Armstrong J, Browne R, Ebright J, Rifkin G. Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis. 1979 Mar-Apr;1(2):386–397. [PubMed]
  • Fernie DS, Thomson RO, Batty I, Walker PD. Active and passive immunization to protect against antibiotic associated caecitis in hamsters. Dev Biol Stand. 1983;53:325–332. [PubMed]
  • Finegold SM. Clinical considerations in the diagnosis of antimicrobial agent-associated gastroenteritis. Diagn Microbiol Infect Dis. 1986 Mar;4(3 Suppl):87S–91S. [PubMed]
  • Florin I, Thelestam M. Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin. Infect Immun. 1981 Jul;33(1):67–74. [PMC free article] [PubMed]
  • Florin I, Thelestam M. Polyphosphate-mediated protection from cellular intoxication with Clostridium difficile toxin B. Biochim Biophys Acta. 1984 Oct 12;805(2):131–136. [PubMed]
  • Florin I, Thelestam M. ADP-ribosylation in cultured cells treated with Clostridium difficile toxin B. Biochem Biophys Res Commun. 1986 Aug 29;139(1):64–70. [PubMed]
  • Florin I, Thelestam M. Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microb Pathog. 1986 Aug;1(4):373–385. [PubMed]
  • Fournier G, Orgiazzi J, Lenoir B, Dechavanne M. Pseudomembranous colitis probably due to rifampicin. Lancet. 1980 Jan 12;1(8159):101–101. [PubMed]
  • Frieben WR, Duncan CL. Homology between enterotoxin protein and spore structural protein in Clostridium perfringens type A. Eur J Biochem. 1973 Nov 15;39(2):393–401. [PubMed]
  • George RH, Symonds JM, Dimock F, Brown JD, Arabi Y, Shinagawa N, Keighley MR, Alexander-Williams J, Burdon DW. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J. 1978 Mar 18;1(6114):695–695. [PMC free article] [PubMed]
  • George WL. Antimicrobial agent-associated colitis and diarrhea. West J Med. 1980 Aug;133(2):115–123. [PMC free article] [PubMed]
  • George WL. Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects. Rev Infect Dis. 1984 Mar-Apr;6 (Suppl 1):S208–S213. [PubMed]
  • George WL, Sutter VL, Goldstein EJ, Ludwig SL, Finegold SM. Aetiology of antimicrobial-agent-associated colitis. Lancet. 1978 Apr 15;1(8068):802–803. [PubMed]
  • George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol. 1979 Feb;9(2):214–219. [PMC free article] [PubMed]
  • Gianfrilli P, Pantosti A, Luzzi I. Evaluation of gas-liquid chromatography for the rapid diagnosis of Clostridium difficile associated disease. J Clin Pathol. 1985 Jun;38(6):690–693. [PMC free article] [PubMed]
  • Gilligan PH, McCarthy LR, Genta VM. Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol. 1981 Jul;14(1):26–31. [PMC free article] [PubMed]
  • Goulston SJ, McGovern VJ. Pseudo-membranous colitis. Gut. 1965 Jun;6(3):207–212. [PMC free article] [PubMed]
  • Greenfield C, Aguilar Ramirez JR, Pounder RE, Williams T, Danvers M, Marper SR, Noone P. Clostridium difficile and inflammatory bowel disease. Gut. 1983 Aug;24(8):713–717. [PMC free article] [PubMed]
  • Preston KM, Griffin J. Complex wound management: a case study. Rehabil Nurs. 1989 Sep-Oct;14(5):269–270. [PubMed]
  • Gurwith MJ, Langston C, Citron DM. Toxin-producing bacteria in infants. Lack of an association with sudden infant death syndrome. Am J Dis Child. 1981 Dec;135(12):1104–1106. [PubMed]
  • Gurwith MJ, Rabin HR, Love K. Diarrhea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study. J Infect Dis. 1977 Mar;135 (Suppl):S104–S110. [PubMed]
  • Hächler H, Wüst J. Reexamination by bacteriophage typing of Clostridium difficile strains isolated during a nosocomial outbreak. J Clin Microbiol. 1984 Sep;20(3):604–604. [PMC free article] [PubMed]
  • Hafiz S, McEntegart MG, Morton RS, Waitkins SA. Clostridium defficiel in the urogenital tract of males and females. Lancet. 1975 Feb 22;1(7904):420–421. [PubMed]
  • Han VK, Sayed H, Chance GW, Brabyn DG, Shaheed WA. An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy? Pediatrics. 1983 Jun;71(6):935–941. [PubMed]
  • Hanfland P, Egge H, Dabrowski U, Kuhn S, Roelcke D, Dabrowski J. Isolation and characterization of an I-active ceramide decasaccharide from rabbit erythrocyte membranes. Biochemistry. 1981 Sep 1;20(18):5310–5319. [PubMed]
  • Haslam SC, Ketley JM, Mitchell TJ, Stephen J, Burdon DW, Candy DC. Growth of Clostridium difficile and production of toxins A and B in complex and defined media. J Med Microbiol. 1986 Jun;21(4):293–297. [PubMed]
  • Holst E, Helin I, Mårdh PA. Recovery of Clostridium difficile from children. Scand J Infect Dis. 1981;13(1):41–45. [PubMed]
  • Humphrey CD, Lushbaugh WB, Condon CW, Pittman JC, Pittman FE. Light and electron microscopic studies of antibiotic associated colitis in the hamster. Gut. 1979 Jan;20(1):6–15. [PMC free article] [PubMed]
  • Jarvis W, Nunez-Montiel O, Thompson F, Dowell V, Towns M, Morris G, Hill E. Comparison of bacterial isolation, cytotoxicity assay, and counterimmunoelectrophoresis for the detection of Clostridium difficile and its toxin. J Infect Dis. 1983 Apr;147(4):778–778. [PubMed]
  • Jarvis W, Nunez-Monteil O, Thompson F, Dowell V, Towns M, Morris G, Vogler W, Winton E, Hill E. False-positive counterimmunoelectrophoresis tests for Clostridium difficile: the role of Clostridium bifermentans and Clostridium sordellii. J Infect Dis. 1983 Dec;148(6):1168–1169. [PubMed]
  • Jones RL, Adney WS, Shideler RK. Isolation of Clostridium difficile and detection of cytotoxin in the feces of diarrheic foals in the absence of antimicrobial treatment. J Clin Microbiol. 1987 Jul;25(7):1225–1227. [PMC free article] [PubMed]
  • Justus PG, Martin JL, Goldberg DA, Taylor NS, Bartlett JG, Alexander RW, Mathias JR. Myoelectric effects of Clostridium difficile: motility-altering factors distinct from its cytotoxin and enterotoxin in rabbits. Gastroenterology. 1982 Oct;83(4):836–843. [PubMed]
  • Kabins SA, Spira TJ. Outbreak of clindamycin-associated colitis. Ann Intern Med. 1975 Dec;83(6):830–831. [PubMed]
  • Khan MY, Hall WH. Staphylococcal enterocolitis--treatment with oral vancomycin. Ann Intern Med. 1966 Jul;65(1):1–8. [PubMed]
  • Kamiya S, Nakamura S, Yamakawa K, Nishida S. Evaluation of a commercially available latex immunoagglutination test kit for detection of Clostridium difficile D-1 toxin. Microbiol Immunol. 1986;30(2):177–181. [PubMed]
  • Keighley MR, Youngs D, Johnson M, Allan RN, Burdon DW. Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease. Gut. 1982 May;23(5):410–414. [PMC free article] [PubMed]
  • Kelly MT, Champagne SG, Sherlock CH, Noble MA, Freeman HJ, Smith JA. Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea. J Clin Microbiol. 1987 Jul;25(7):1244–1247. [PMC free article] [PubMed]
  • Ketley JM, Haslam SC, Mitchell TJ, Stephen J, Candy DC, Burdon DW. Production and release of toxins A and B by Clostridium difficile. J Med Microbiol. 1984 Dec;18(3):385–391. [PubMed]
  • Ketley JM, Mitchell TJ, Haslam SC, Stephen J, Candy DC, Burdon DW. Sporogenesis and toxin A production by Clostridium difficile. J Med Microbiol. 1986 Aug;22(1):33–38. [PubMed]
  • Kim K, DuPont HL, Pickering LK. Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. J Pediatr. 1983 Mar;102(3):376–382. [PubMed]
  • Kim K, Pickering LK, DuPont HL, Sullivan N, Wilkins T. In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile. J Infect Dis. 1984 Jul;150(1):57–62. [PubMed]
  • Kim KH, Fekety R, Batts DH, Brown D, Cudmore M, Silva J, Jr, Waters D. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981 Jan;143(1):42–50. [PubMed]
  • Knoop FC. Clindamycin-associated enterocolitis in guinea pigs: evidence for a bacterial toxin. Infect Immun. 1979 Jan;23(1):31–33. [PMC free article] [PubMed]
  • Kreutzer EW, Milligan FD. Treatment of antibiotic-associated pseudomembranous colitis with cholestyramine resin. Johns Hopkins Med J. 1978 Sep;143(3):67–72. [PubMed]
  • Krishnan C. Detection of Clostridium difficile toxins by enzyme immunoassay. J Hyg (Lond) 1986 Feb;96(1):5–12. [PMC free article] [PubMed]
  • Krivan HC, Clark GF, Smith DF, Wilkins TD. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun. 1986 Sep;53(3):573–581. [PMC free article] [PubMed]
  • Krivan HC, Wilkins TD. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun. 1987 Aug;55(8):1873–1877. [PMC free article] [PubMed]
  • Kudhair A, Delmée M, Wauters G. Rapid identification of Clostridium difficile by determination of leucine arylamidase activity. Eur J Clin Microbiol. 1986 Apr;5(2):160–161. [PubMed]
  • Kuijper EJ, Oudbier JH, Stuifbergen WN, Jansz A, Zanen HC. Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea. J Clin Microbiol. 1987 Apr;25(4):751–753. [PMC free article] [PubMed]
  • LaMont JT, Trnka YM. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet. 1980 Feb 23;1(8165):381–383. [PubMed]
  • Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis. 1982 Dec;146(6):727–733. [PubMed]
  • Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet. 1978 May 20;1(8073):1063–1066. [PubMed]
  • Larson HE, Parry JV, Price AB, Davies DR, Dolby J, Tyrrell DA. Undescribed toxin in pseudomembranous colitis. Br Med J. 1977 May 14;1(6071):1246–1248. [PMC free article] [PubMed]
  • Larson HE, Price AB. Pseudomembranous colitis: Presence of clostridial toxin. Lancet. 1977 Dec 24;2(8052-8053):1312–1314. [PubMed]
  • Laughon BE, Viscidi RP, Gdovin SL, Yolken RH, Bartlett JG. Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infect Dis. 1984 May;149(5):781–788. [PubMed]
  • Levett PN. Detection of Clostridium difficile in faeces by direct gas liquid chromatography. J Clin Pathol. 1984 Feb;37(2):117–119. [PMC free article] [PubMed]
  • Levett PN. Effect of antibiotic concentration in a selective medium on the isolation of Clostridium difficile from faecal specimens. J Clin Pathol. 1985 Feb;38(2):233–234. [PMC free article] [PubMed]
  • Levett PN. Identification of Clostridium difficile using the API ZYM system. Eur J Clin Microbiol. 1985 Oct;4(5):505–507. [PubMed]
  • Levett PN. Clostridium difficile in habitats other than the human gastro-intestinal tract. J Infect. 1986 May;12(3):253–263. [PubMed]
  • Levett PN, Phillips KD. Gas chromatographic identification of Clostridium difficile and detection of cytotoxin from a modified selective medium. J Clin Pathol. 1985 Jan;38(1):82–85. [PMC free article] [PubMed]
  • Libby JM, Donta ST, Wilkins TD. Clostridium difficile toxin A in infants. J Infect Dis. 1983 Sep;148(3):606–606. [PubMed]
  • Libby JM, Jortner BS, Wilkins TD. Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun. 1982 May;36(2):822–829. [PMC free article] [PubMed]
  • Libby JM, Wilkins TD. Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies. Infect Immun. 1982 Jan;35(1):374–376. [PMC free article] [PubMed]
  • Lönnroth I, Lange S. Toxin A of Clostridium difficile: production, purification and effect in mouse intestine. Acta Pathol Microbiol Immunol Scand B. 1983 Dec;91(6):395–400. [PubMed]
  • Lüderitz O, Simmons DA, Westphal G. The immunochemistry of Salmonella chemotype VI O-antigens. The structure of oligosaccharides from Salmonella group U (o 43) lipopolysaccharides. Biochem J. 1965 Dec;97(3):820–826. [PubMed]
  • Lusk RH, Fekety R, Silva J, Browne RA, Ringler DH, Abrams GD. Clindamycin-induced enterocolitis in hamsters. J Infect Dis. 1978 Apr;137(4):464–475. [PubMed]
  • Lyerly DM, Lockwood DE, Richardson SH, Wilkins TD. Biological activities of toxins A and B of Clostridium difficile. Infect Immun. 1982 Mar;35(3):1147–1150. [PMC free article] [PubMed]
  • Lyerly DM, Phelps CJ, Toth J, Wilkins TD. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun. 1986 Oct;54(1):70–76. [PMC free article] [PubMed]
  • Lyerly DM, Phelps CJ, Wilkins TD. Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol. 1985 Jan;21(1):12–14. [PMC free article] [PubMed]
  • Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun. 1985 Feb;47(2):349–352. [PMC free article] [PubMed]
  • Lyerly DM, Sullivan NM, Wilkins TD. Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol. 1983 Jan;17(1):72–78. [PMC free article] [PubMed]
  • Lyerly DM, Wilkins TD. Commercial latex test for Clostridium difficile toxin A does not detect toxin A. J Clin Microbiol. 1986 Mar;23(3):622–623. [PMC free article] [PubMed]
  • Mahony DE, Bell PD, Easterbrook KB. Two bacteriophages of Clostridium difficile. J Clin Microbiol. 1985 Feb;21(2):251–254. [PMC free article] [PubMed]
  • Makin T. Rapid identification of Clostridium difficile by direct detection of volatile organic acids from primary isolation media. J Clin Pathol. 1984 Jun;37(6):711–712. [PMC free article] [PubMed]
  • Malamou-Ladas H, O'Farrell S, Nash JQ, Tabaqchali S. Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol. 1983 Jan;36(1):88–92. [PMC free article] [PubMed]
  • Mårdh PA, Helin I, Colleen I, Oberg M, Holst E. Clostridium difficile toxin in faecal specimens of healthy children and children with diarrhoea. Acta Paediatr Scand. 1982 Mar;71(2):275–278. [PubMed]
  • Marler L, Allen S, Siders J. Rapid enzymatic characterization of clinically encountered anaerobic bacteria with the API ZYM system. Eur J Clin Microbiol. 1984 Aug;3(4):294–300. [PubMed]
  • Massot J, Sanchez O, Couchy R, Astoin J, Parodi AL. Bacterio-pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamster. Arzneimittelforschung. 1984;34(7):794–797. [PubMed]
  • Meyers S, Mayer L, Bottone E, Desmond E, Janowitz HD. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology. 1981 Apr;80(4):697–670. [PubMed]
  • Mitchell TJ, Ketley JM, Haslam SC, Stephen J, Burdon DW, Candy DC, Daniel R. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut. 1986 Jan;27(1):78–85. [PMC free article] [PubMed]
  • Moskovitz M, Bartlett JG. Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy. Arch Intern Med. 1981 Apr;141(5):663–664. [PubMed]
  • Muldrow LL, Archibold ER, Nunez-Montiel OL, Sheehy RJ. Survey of the extrachromosomal gene pool of Clostridium difficile. J Clin Microbiol. 1982 Oct;16(4):637–640. [PMC free article] [PubMed]
  • Mulligan ME. Epidemiology of Clostridium difficile-induced intestinal disease. Rev Infect Dis. 1984 Mar-Apr;6 (Suppl 1):S222–S228. [PubMed]
  • Mulligan ME, Halebian S, Kwok RY, Cheng WC, Finegold SM, Anselmo CR, Gerding DN, Peterson LR. Bacterial agglutination and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Infect Dis. 1986 Feb;153(2):267–271. [PubMed]
  • Nachamkin I, Lotz-Nolan L, Skalina D. Evaluation of a commercial cytotoxicity assay for detection of Clostridium difficile toxin. J Clin Microbiol. 1986 May;23(5):954–955. [PMC free article] [PubMed]
  • Nakamura S, Mikawa M, Tanabe N, Yamakawa K, Nishida S. Effect of clindamycin on cytotoxin production by Clostridium difficile. Microbiol Immunol. 1982;26(11):985–992. [PubMed]
  • Nakamura S, Tanabe N, Yamakawa K, Nishida S. Cytotoxin production by Clostridium sordellii strains. Microbiol Immunol. 1983;27(6):495–502. [PubMed]
  • O'Farrell S, Wilks M, Nash JQ, Tabaqchali S. A selective enrichment broth for the isolation of Clostridium difficile. J Clin Pathol. 1984 Jan;37(1):98–99. [PMC free article] [PubMed]
  • Onderdonk AB, Cisneros RL, Bartlett JG. Clostridium difficile in gnotobiotic mice. Infect Immun. 1980 Apr;28(1):277–282. [PMC free article] [PubMed]
  • Onderdonk AB, Lowe BR, Bartlett JG. Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation. Appl Environ Microbiol. 1979 Oct;38(4):637–641. [PMC free article] [PubMed]
  • Orchard JL, Fekety R, Smith JR. Antibiotic-associated colitis due to Clostridium difficile in a Kodiak bear. Am J Vet Res. 1983 Aug;44(8):1547–1548. [PubMed]
  • Peach SL, Borriello SP, Gaya H, Barclay FE, Welch AR. Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis. J Clin Pathol. 1986 Sep;39(9):1013–1018. [PMC free article] [PubMed]
  • Peikin SR, Galdibini J, Bartlett JG. Role of Clostridium difficile in a case of nonantibiotic-associated pseudomembranous colitis. Gastroenterology. 1980 Nov;79(5 Pt 1):948–951. [PubMed]
  • Pepersack F, Labbe M, Nonhoff C, Schoutens E. Use of gas-liquid chromatography as a screening test for toxigenic Clostridium difficile in diarrhoeal stools. J Clin Pathol. 1983 Nov;36(11):1233–1236. [PMC free article] [PubMed]
  • Peters BP, Goldstein IJ. The use of fluorescein-conjugated Bandeiraea simplicifolia B4-isolectin as a histochemical reagent for the detection of alpha-D-galactopyranosyl groups. Their occurrence in basement membranes. Exp Cell Res. 1979 May;120(2):321–334. [PubMed]
  • Peterson LR, Holter JJ, Shanholtzer CJ, Garrett CR, Gerding DN. Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test. Am J Clin Pathol. 1986 Aug;86(2):208–211. [PubMed]
  • Peterson LR, Holter JJ, Shanholtzer CJ, Garrett CR, Gerding DN. Detection of C. difficile toxin A (enterotoxin) Am J Clin Pathol. 1987 Feb;87(2):298–299. [PubMed]
  • Phua TJ, Rogers TR, Pallett AP. Prospective study of Clostridium difficile colonization and paracresol detection in the stools of babies on a special care unit. J Hyg (Lond) 1984 Aug;93(1):17–25. [PMC free article] [PubMed]
  • Pierce PF, Jr, Wilson R, Silva J, Jr, Garagusi VF, Rifkin GD, Fekety R, Nunez-Montiel O, Dowell VR, Jr, Hughes JM. Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis. 1982 Feb;145(2):269–274. [PubMed]
  • Popoff MR. Bacteriological examination in enterotoxaemia of sheep and lamb. Vet Rec. 1984 Mar 31;114(13):324–324. [PubMed]
  • Popoff MR. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun. 1987 Jan;55(1):35–43. [PMC free article] [PubMed]
  • Pothoulakis C, Barone LM, Ely R, Faris B, Clark ME, Franzblau C, LaMont JT. Purification and properties of Clostridium difficile cytotoxin B. J Biol Chem. 1986 Jan 25;261(3):1316–1321. [PubMed]
  • Pothoulakis C, Triadafilopoulos G, Clark M, Franzblau C, LaMont JT. Clostridium difficile cytotoxin inhibits protein synthesis in fibroblasts and intestinal mucosa. Gastroenterology. 1986 Nov;91(5):1147–1153. [PubMed]
  • Potvliege C, Labbé M, Yourassowsky E. Gas-liquid chromatography as screening test for Clostridium difficile. Lancet. 1981 Nov 14;2(8255):1105–1105. [PubMed]
  • Poxton IR, Aronsson B, Möllby R, Nord CE, Collee JG. Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea. J Med Microbiol. 1984 Jun;17(3):317–324. [PubMed]
  • Poxton IR, Byrne MD. Detection of Clostridium difficile toxin by counterimmunoelectrophoresis: a note of caution. J Clin Microbiol. 1981 Sep;14(3):349–349. [PMC free article] [PubMed]
  • Poxton IR, Byrne MD. Immunological analysis of the EDTA-soluble antigens of Clostridium difficile and related species. J Gen Microbiol. 1981 Jan;122(1):41–46. [PubMed]
  • Poxton IR, Byrne MD. Demonstration of shared antigens in the genus Clostridium by an enzyme-linked immunosorbent assay. J Med Microbiol. 1984 Apr;17(2):171–176. [PubMed]
  • Poxton IR, Cartmill TD. Immunochemistry of the cell-surface carbohydrate antigens of Clostridium difficile. J Gen Microbiol. 1982 Jun;128(6):1365–1370. [PubMed]
  • Price AB, Larson HE, Crow J. Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea. Gut. 1979 Jun;20(6):467–475. [PMC free article] [PubMed]
  • Prigogine T, Potvliege C, Burette A, Verbeet T, Schmerber J. Pseudomembranous colitis and rifampicin. Chest. 1981 Dec;80(6):766–767. [PubMed]
  • Ramirez-Ronda CH. Letter: Incidence of clindamycin-associated colitis. Ann Intern Med. 1974 Dec;81(6):860–860. [PubMed]
  • Rautenberg P, Stender F, Ullmann U. Detection of Clostridium difficile Toxin A by immunoblotting. Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Feb;261(1):29–42. [PubMed]
  • Rehg JE. Cecal toxin(s) from guinea pigs with clindamycin-associated colitis, neutralized by Clostridium sordellii antitoxin. Infect Immun. 1980 Feb;27(2):387–390. [PMC free article] [PubMed]
  • Rehg JE, Pakes SP. Implication of Clostridium difficile and Clostridium perfringens iota toxins in experimental lincomycin-associated colitis of rabbits. Lab Anim Sci. 1982 Jun;32(3):253–257. [PubMed]
  • Richards SM, Hunt BW. Clostridium sordellii in lambs. Vet Rec. 1982 Jul 3;111(1):22–22. [PubMed]
  • Rietra PJ, Slaterus KW, Zanen HC, Meuwissen SG. Clostridial toxin in faeces of healthy infants. Lancet. 1978 Aug 5;2(8084):319–319. [PubMed]
  • Rifkin GD, Silva J, Jr, Fekety R. Gastrointestinal and systemic toxicity of fecal extracts from hamsters with clindamycin-induced colitis. Gastroenterology. 1978 Jan;74(1):52–57. [PubMed]
  • Rifkin GD, Fekety FR, Silva J., Jr Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin. Lancet. 1977 Nov 26;2(8048):1103–1106. [PubMed]
  • Rihn B, Beck G, Monteil H, Lecerf F, Girardot R. Effect of the cytotoxin of Clostridium difficile on cultured hepatoma cells. Biol Cell. 1985;53(1):23–32. [PubMed]
  • Rihn B, Scheftel JM, Girardot R, Monteil H. A new purification procedure for Clostridium difficile enterotoxin. Biochem Biophys Res Commun. 1984 Nov 14;124(3):690–695. [PubMed]
  • Robert A, Bundy GL, Field SO, Nezamis JE, Davis JP, Hanchar AJ, Lancaster C, Ruwart MJ. Prevention of cecitis in hamsters by certain prostaglandins. Prostaglandins. 1985 Jun;29(6):961–980. [PubMed]
  • Rocca JM, Pieterse AS, Rowland R, Hecker R, Rich GE. Clostridium difficile colitis. Aust N Z J Med. 1984 Oct;14(5):606–610. [PubMed]
  • Rolfe RD, Iaconis JP. Intestinal colonization of infant hamsters with Clostridium difficile. Infect Immun. 1983 Nov;42(2):480–486. [PMC free article] [PubMed]
  • Ruwart MJ, Renis HE, Erlandson AL, DeHaan RM, Nezamis JE, Lancaster C, Davis JP. 16,16-dimethyl-prostaglandin E2 inhibits toxin release from Clostridium difficile. Adv Prostaglandin Thromboxane Leukot Res. 1983;12:93–98. [PubMed]
  • Ryan RW. Considerations in the laboratory diagnosis of antibiotic-associated gastroenteritis. Diagn Microbiol Infect Dis. 1986 Mar;4(3 Suppl):79S–86S. [PubMed]
  • Saginur R, Fogel R, Begin L, Cohen B, Mendelson J. Splenic abscess due to Clostridium difficile. J Infect Dis. 1983 Jun;147(6):1105–1105. [PubMed]
  • Sands M, Yungbluth M, Sommers HM. The non-value of counterimmunoelectrophoresis for the direct rapid detection of Clostridium difficile toxin in stool filtrates. Am J Clin Pathol. 1983 Mar;79(3):375–377. [PubMed]
  • Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis. 1984;16(2):211–215. [PubMed]
  • Sell TL, Schaberg DR, Fekety FR. Bacteriophage and bacteriocin typing scheme for Clostridium difficile. J Clin Microbiol. 1983 Jun;17(6):1148–1152. [PMC free article] [PubMed]
  • Sherertz RJ, Sarubbi FA. The prevalence of Clostridium difficile and toxin in a nursery population: a comparison between patients with necrotizing enterocolitis and an asymptomatic group. J Pediatr. 1982 Mar;100(3):435–439. [PubMed]
  • Silva J, Fekety R, Werk C, Ebright J, Cudmore M, Batts D, Syrjamaki C, Lukens J. Inciting and etiologic agents of colitis. Rev Infect Dis. 1984 Mar-Apr;6 (Suppl 1):S214–S221. [PubMed]
  • Small JD. Fatal enterocolitis in hamsters given lincomycin hydrochloride. Lab Anim Care. 1968 Aug;18(4):411–420. [PubMed]
  • Smith MF, Borriello SP, Clayden GS, Casewell MW. Clinical and bacteriological findings in necrotising enterocolitis: a controlled study. J Infect. 1980 Mar;2(1):23–31. [PubMed]
  • Stark PL, Lee A, Parsonage BD. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun. 1982 Mar;35(3):895–899. [PMC free article] [PubMed]
  • Stephen J, Redmond SC, Mitchell TJ, Ketley J, Candy DC, Burdon DW, Daniel R. Clostridium difficile enterotoxin (toxin A): new results. Biochem Soc Trans. 1984 Apr;12(2):194–195. [PubMed]
  • STERNE M, WENTZEL LM. A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D. J Immunol. 1950 Aug;65(2):175–183. [PubMed]
  • Sugiyama T, Mukai M, Yamashita R, Sunakawa K. Experimental models of Clostridium difficile enterocolitis in gnotobiotic mice. Prog Clin Biol Res. 1985;181:203–206. [PubMed]
  • Sullivan NM, Pellett S, Wilkins TD. Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun. 1982 Mar;35(3):1032–1040. [PMC free article] [PubMed]
  • Svedhem A, Kaijser B, MacDowall I. Intestinal occurrence of Campylobacter fetus subspecies jejuni and Clostridium difficile in children in Sweden. Eur J Clin Microbiol. 1982 Feb;1(1):29–32. [PubMed]
  • Swartzberg JE, Maresca RM, Remington JS. Clinical study of gastrointestinal complications associated with clindamycin therapy. J Infect Dis. 1977 Mar;135 (Suppl):S99–103. [PubMed]
  • Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, Lee JT., Jr Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet. 1983 Nov 5;2(8358):1043–1046. [PubMed]
  • Tedesco FJ. Clindamycin-associated colitis. Review of the clinical spectrum of 47 cases. Am J Dig Dis. 1976 Jan;21(1):26–32. [PubMed]
  • Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis. A prospective study. Ann Intern Med. 1974 Oct;81(4):429–433. [PubMed]
  • Tedesco FJ, Napier J, Gamble W, Chang TW, Bartlett JG. Therapy of antibiotic-associated pseudomembranous colitis. J Clin Gastroenterol. 1979 Mar;1(1):51–54. [PubMed]
  • Thelestam M, Brönnegård M. Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture. Scand J Infect Dis Suppl. 1980;(Suppl 22):16–29. [PubMed]
  • Toffler RB, Pingoud EG, Burrell MI. Acute colitis related to penicillin and penicillin derivatives. Lancet. 1978 Sep 30;2(8092 Pt 1):707–709. [PubMed]
  • Toothaker RD, Elmer GW. Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii. Antimicrob Agents Chemother. 1984 Oct;26(4):552–556. [PMC free article] [PubMed]
  • Torres JF, Cedillo R, Sánchez J, Dillman C, Giono S, Muñoz O. Prevalence of Clostridium difficile and its cytotoxin in infants in Mexico. J Clin Microbiol. 1984 Aug;20(2):274–275. [PMC free article] [PubMed]
  • Trnka YM, LaMont JT. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology. 1981 Apr;80(4):693–696. [PubMed]
  • Vesikari T, Isolauri E, Mäki M, Grönroos P. Clostridium difficile in young children. Association with antibiotic usage. Acta Paediatr Scand. 1984 Jan;73(1):86–91. [PubMed]
  • Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology. 1981 Jul;81(1):5–9. [PubMed]
  • Viscidi RP, Bartlett JG. Antibiotic-associated pseudomembranous colitis in children. Pediatrics. 1981 Mar;67(3):381–386. [PubMed]
  • Wada N, Nishida N, Iwaki S, Ohi H, Miyawaki T, Taniguchi N, Migita S. Neutralizing activity against Clostridium difficile toxin in the supernatants of cultured colostral cells. Infect Immun. 1980 Aug;29(2):545–550. [PMC free article] [PubMed]
  • Wald A, Mendelow H, Bartlett JG. Non-antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. Ann Intern Med. 1980 Jun;92(6):798–799. [PubMed]
  • Walker RC, Ruane PJ, Rosenblatt JE, Lyerly DM, Gleaves CA, Smith TF, Pierce PF, Jr, Wilkins TD. Comparison of culture, cytotoxicity assays, and enzyme-linked immunosorbent assay for toxin A and toxin B in the diagnosis of Clostridium difficile-related enteric disease. Diagn Microbiol Infect Dis. 1986 May;5(1):61–69. [PubMed]
  • Welkon CJ, Long SS, Thompson CM, Jr, Gilligan PH. Clostridium difficile in patients with cystic fibrosis. Am J Dis Child. 1985 Aug;139(8):805–808. [PubMed]
  • West SE, Wilkins TD. Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin. J Clin Microbiol. 1982 Feb;15(2):347–349. [PMC free article] [PubMed]
  • Wilson KH, Kennedy MJ, Fekety FR. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol. 1982 Mar;15(3):443–446. [PMC free article] [PubMed]
  • Wilson KH, Sheagren JN, Freter R, Weatherbee L, Lyerly D. Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. J Infect Dis. 1986 Mar;153(3):547–551. [PubMed]
  • Wilson KH, Silva J, Fekety FR. Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect Immun. 1981 Nov;34(2):626–628. [PMC free article] [PubMed]
  • Wu TC, Fung JC. Evaluation of the usefulness of counterimmunoelectrophoresis for diagnosis of Clostridium difficile-associated colitis in clinical specimens. J Clin Microbiol. 1983 Apr;17(4):610–613. [PMC free article] [PubMed]
  • Wu TC, Gersch SM. Evaluation of a commercial kit for the routine detection of Clostridium difficile cytotoxin by tissue culture. J Clin Microbiol. 1986 Apr;23(4):792–793. [PMC free article] [PubMed]
  • Wu TC, McCarthy VP, Gill VJ. Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis. J Infect Dis. 1983 Jul;148(1):176–176. [PubMed]
  • Yamakawa K, Nakamura S, Nishida S. Separation of two cytotoxins of Clostridium sordellii strains. Microbiol Immunol. 1985;29(6):553–557. [PubMed]
  • Yamakawa K, Nishida S, Nakamura S. C2 toxicity in extract of Clostridium botulinum type C spores. Infect Immun. 1983 Aug;41(2):858–860. [PMC free article] [PubMed]
  • Young GP, Ward PB, Bayley N, Gordon D, Higgins G, Trapani JA, McDonald MI, Labrooy J, Hecker R. Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. Gastroenterology. 1985 Nov;89(5):1038–1045. [PubMed]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)